{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:59:00Z","timestamp":1791385140736,"version":"4.3.3"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Harold and Marjorie Moss Charitable Trust","award":["DFH\/19986"],"award-info":[{"award-number":["DFH\/19986"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Some community pharmacies in England provide free chlamydia testing to young people, yet testing activity in the setting is low. This study aims to increase understanding of why that is, by investigating community pharmacists\u2019 perceptions of barriers to delivering the service, and the reasons why some do not offer testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Semi-structured interviews were conducted with 22 community pharmacists in North East England between November 2018 and May 2019. The sample comprised both those who provided and did not provide chlamydia testing at the time of the interview. Data were subjected to thematic analysis, utilising the constructs of the normalisation process theory.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Pharmacists found it challenging to sustain delivery of chlamydia testing, as very few young people either requested the test or accepted it when it was offered during consultations on other sexual health services. Pharmacists were cautious about offering the test, having concerns about making clients feel uncomfortable. They identified the value of training to enable them to communicate confidently with clients about testing. Pharmacists supported the suggestion that treatment for chlamydia be offered as part of a \u2018test and treat\u2019 package, as they felt that it aligned to their role in the provision of medicines advice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Community pharmacies are well-placed to deliver chlamydia testing but are not operating as effectively as they might do. The provision of training on communicating with young people, integrating testing with more sexual health services, and providing \u2018test and treatment\u2019 for chlamydia could contribute to greater testing activity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijpp\/riac057","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:38:40Z","timestamp":1658500720000},"page":"507-513","source":"Crossref","is-referenced-by-count":8,"title":["Investigating community pharmacists\u2019 perceptions of delivering chlamydia screening to young people: a qualitative study using normalisation process theory to understand professional practice"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-0204","authenticated-orcid":false,"given":"Lara","family":"Ahmaro","sequence":"first","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lindsey","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Population Health Sciences Institute, Newcastle University , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Forrest","sequence":"additional","affiliation":[{"name":"Department of Sociology, College of St Hild and St Bede, Durham University , Durham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cate","family":"Whittlesea","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, UCL School of Pharmacy, University College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"2023012313015635600_CIT0001","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"2023012313015635600_CIT0002","volume-title":"Sexually Transmitted Infections and Screening for Chlamydia in England, 2020","author":"Ratna","year":"2021"},{"key":"2023012313015635600_CIT0003","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","article-title":"Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection","volume":"334","author":"Scholes","year":"1996","journal-title":"N Engl J Med"},{"key":"2023012313015635600_CIT0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001432-200402000-00010","article-title":"Tubal factor infertility, with special regard to chlamydial salpingitis","volume":"17","author":"Mardh","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"2023012313015635600_CIT0005","author":"Public Health England.","year":"2018","edition":"7"},{"key":"2023012313015635600_CIT0006","volume-title":"Standards for the Management of Sexually Transmitted Infections (STIs)","author":"British Association for Sexual Health and HIV.","year":"2019"},{"key":"2023012313015635600_CIT0007","volume-title":"Information to Support the Commissioning of Chlamydia Screening in General Practice and Community Pharmacies, 2014","author":"Public Health England.","year":"2014"},{"key":"2023012313015635600_CIT0008","volume-title":"The Pharmacy Offer for Sexual Health, Reproductive Health and HIV: A Resource for Commissioners and Providers","author":"Public Health England.","year":"2019"},{"key":"2023012313015635600_CIT0009","volume-title":"Chlamydia Testing Data in 15\u201324 Year Olds, England, 2015\u20132019","author":"Public Health England.","year":"2020"},{"key":"2023012313015635600_CIT0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-9-7","article-title":"Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study.","volume":"9","author":"Brabin","year":"2009","journal-title":"BMC Womens Health"},{"key":"2023012313015635600_CIT0011","doi-asserted-by":"crossref","first-page":"e003338","DOI":"10.1136\/bmjopen-2013-003338","article-title":"To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia","volume":"3","author":"Gudka","year":"2013","journal-title":"BMJ Open"},{"key":"2023012313015635600_CIT0012","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-0528.2009.02362.x","article-title":"A qualitative study of pharmacists\u2019 views on offering chlamydia screening to women requesting emergency hormonal contraception.","volume":"117","author":"Thomas","year":"2010","journal-title":"BJOG"},{"key":"2023012313015635600_CIT0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jfprhc.2010.0003","article-title":"Chlamydia screening by community pharmacists: a qualitative study","volume":"37","author":"Dabrera","year":"2011","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2023012313015635600_CIT0014","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.sapharm.2013.11.006","article-title":"Can pharmacy assistants play a greater role in public health programs in community pharmacies? Lessons from a chlamydia screening study in Canberra, Australia.","volume":"10","author":"Deeks","year":"2014","journal-title":"Res Social Adm Pharm"},{"key":"2023012313015635600_CIT0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/qshc.2006.020883","article-title":"Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London","volume":"16","author":"Baraitser","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"2023012313015635600_CIT0016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1071\/PY12135","article-title":"\u2018Catching Chlamydia\u2019: combining cash incentives and community pharmacy access for increased chlamydia screening, the view of young people.","volume":"21","author":"Parker","year":"2015","journal-title":"Aust J Prim Health"},{"key":"2023012313015635600_CIT0017","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/sextrans-2019-054096","article-title":"Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff","volume":"95","author":"Gauly","year":"2019","journal-title":"Sex Transm Infect"},{"key":"2023012313015635600_CIT0018","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.srhc.2018.03.006","article-title":"Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland.","volume":"16","author":"Arnet","year":"2018","journal-title":"Sex Reprod Healthc"},{"key":"2023012313015635600_CIT0019","author":"NHS.","year":"2018"},{"key":"2023012313015635600_CIT0020","volume-title":"Pharmaceutical Services Negotiating Committee Pharmacy Services Spreadsheet","author":"Pharmaceutical Services Negotiating Committee.","year":"2021"},{"key":"2023012313015635600_CIT0021","doi-asserted-by":"crossref","first-page":"e052228","DOI":"10.1136\/bmjopen-2021-052228","article-title":"Young people\u2019s perceptions of accessing a community pharmacy for a chlamydia testing kit: a qualitative study based in North East England","volume":"11","author":"Ahmaro","year":"2021","journal-title":"BMJ Open"},{"key":"2023012313015635600_CIT0022","volume-title":"The English Indices of Deprivation 2015","author":"Department for Communities and Local Government.","year":"2015"},{"key":"2023012313015635600_CIT0023","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/sextrans-2015-052013","article-title":"Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).","volume":"92","author":"Woodhall","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2023012313015635600_CIT0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0038038509103208","article-title":"Implementing, embedding, and integrating practices: an outline of normalization process theory","volume":"43","author":"May","year":"2009","journal-title":"Sociology"},{"key":"2023012313015635600_CIT0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/erp.10.30","article-title":"Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research","volume":"10","author":"Kerr","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2023012313015635600_CIT0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2023012313015635600_CIT0027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0735275112457914","article-title":"Theory construction in qualitative research: from grounded theory to abductive analysis","volume":"30","author":"Timmermans","year":"2012","journal-title":"Sociol Theory"},{"key":"2023012313015635600_CIT0028","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"2023012313015635600_CIT0029","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/pharmacy8040206","article-title":"Staff and users\u2019 experiences of pharmacy-based sexual and reproductive health services: a qualitative interview study from the UK.","volume":"8","author":"Gauly","year":"2020","journal-title":"Pharmacy"},{"key":"2023012313015635600_CIT0030","volume-title":"Quality Criteria for Young People Friendly Health Services","author":"Department of Health.","year":"2011"},{"key":"2023012313015635600_CIT0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jphs.12125","article-title":"Applying the \u2018You\u2019re Welcome\u2019 youth-friendly service criteria to community pharmacy in the UK.","volume":"7","author":"Alsaleh","year":"2016","journal-title":"J Pharm Health Serv Res"},{"key":"2023012313015635600_CIT0032","volume-title":"The Community Pharmacy Contractual Framework for 2019\/20 to 2023\/24: Supporting Delivery for the NHS Long Term Plan","author":"Department of Health and Social Care.","year":"2019"},{"key":"2023012313015635600_CIT0033","volume-title":"Press Release: First Progestogen-Only Contraceptive Pills to be Available to Purchase from Pharmacies","author":"Medicines and Healthcare products Regulatory Agency.","year":"2021"},{"key":"2023012313015635600_CIT0034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11096-010-9460-3","article-title":"A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment.","volume":"33","author":"Anderson","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"2023012313015635600_CIT0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1211\/jphsr.01.01.0013","article-title":"Views of the general public on the role of pharmacy in public health","volume":"1","author":"Krska","year":"2010","journal-title":"J Pharm Health Serv Res"},{"key":"2023012313015635600_CIT0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.sapharm.2012.05.006","article-title":"How to enhance public health service utilization in community pharmacy? General public and health providers\u2019 perspectives","volume":"10","author":"Saramunee","year":"2014","journal-title":"Res Social Adm Pharm"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/30\/6\/507\/48829383\/riac057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/30\/6\/507\/48829383\/riac057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:50:18Z","timestamp":1674485418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/30\/6\/507\/6648484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riac057","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,7,22]]}}}